AXL and neoplasm: The presence of these AXL-positive cells was not restricted to tumor-derived cell lines harboring EGFR-oncogenic mutations, as we observed that a similar percentage of AXL-positive cells were present also in cell lines driven for example by mutant KRAS (i.e., A549) (Figure 1C,D).